Clinical trial
A Single-Dose, Open-Label, Randomized, Two-Way Crossover Food Effect Study of Lofexidine 400 μg (2 x 200 μg) Tablets
NCT01437306 is registered in ClinicalTrials.gov with USWM, LLC (dba US WorldMeds) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Single-Dose, Open-Label, Randomized, Two-Way Crossover Food Effect Study of Lofexidine 400 μg (2 x 200 μg) Tablets
- Lead sponsor
- USWM, LLC (dba US WorldMeds)
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- October 31, 2011
- Completion date
- October 31, 2011
- Enrollment
- 13 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthy